Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2158764984;64985;64986 chr2:178584882;178584881;178584880chr2:179449609;179449608;179449607
N2AB1994660061;60062;60063 chr2:178584882;178584881;178584880chr2:179449609;179449608;179449607
N2A1901957280;57281;57282 chr2:178584882;178584881;178584880chr2:179449609;179449608;179449607
N2B1252237789;37790;37791 chr2:178584882;178584881;178584880chr2:179449609;179449608;179449607
Novex-11264738164;38165;38166 chr2:178584882;178584881;178584880chr2:179449609;179449608;179449607
Novex-21271438365;38366;38367 chr2:178584882;178584881;178584880chr2:179449609;179449608;179449607
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: D
  • RefSeq wild type transcript codon: GAC
  • RefSeq wild type template codon: CTG
  • Domain: Fn3-44
  • Domain position: 29
  • Structural Position: 30
  • Q(SASA): 0.3443
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
D/G None None 0.928 N 0.693 0.523 0.51230852224 gnomAD-4.0.0 1.59218E-06 None None None None I None 0 0 None 0 0 None 0 0 2.85982E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
D/A 0.9094 likely_pathogenic 0.8902 pathogenic -0.147 Destabilizing 0.957 D 0.701 prob.neutral N 0.493551644 None None I
D/C 0.9912 likely_pathogenic 0.9875 pathogenic 0.238 Stabilizing 0.999 D 0.732 prob.delet. None None None None I
D/E 0.8566 likely_pathogenic 0.8113 pathogenic -0.577 Destabilizing 0.092 N 0.235 neutral N 0.491221013 None None I
D/F 0.9908 likely_pathogenic 0.987 pathogenic -0.436 Destabilizing 0.999 D 0.745 deleterious None None None None I
D/G 0.8519 likely_pathogenic 0.8345 pathogenic -0.386 Destabilizing 0.928 D 0.693 prob.neutral N 0.517949776 None None I
D/H 0.9616 likely_pathogenic 0.9523 pathogenic -0.808 Destabilizing 0.997 D 0.725 prob.delet. N 0.510441358 None None I
D/I 0.9804 likely_pathogenic 0.9708 pathogenic 0.438 Stabilizing 0.992 D 0.768 deleterious None None None None I
D/K 0.9716 likely_pathogenic 0.9663 pathogenic 0.157 Stabilizing 0.968 D 0.665 neutral None None None None I
D/L 0.9726 likely_pathogenic 0.9615 pathogenic 0.438 Stabilizing 0.983 D 0.757 deleterious None None None None I
D/M 0.9854 likely_pathogenic 0.9796 pathogenic 0.856 Stabilizing 0.999 D 0.735 prob.delet. None None None None I
D/N 0.4044 ambiguous 0.3109 benign -0.064 Destabilizing 0.978 D 0.721 prob.delet. N 0.468623761 None None I
D/P 0.9858 likely_pathogenic 0.9819 pathogenic 0.268 Stabilizing 0.992 D 0.756 deleterious None None None None I
D/Q 0.9666 likely_pathogenic 0.9612 pathogenic -0.01 Destabilizing 0.968 D 0.758 deleterious None None None None I
D/R 0.9785 likely_pathogenic 0.977 pathogenic 0.031 Stabilizing 0.983 D 0.759 deleterious None None None None I
D/S 0.7386 likely_pathogenic 0.6947 pathogenic -0.186 Destabilizing 0.895 D 0.691 prob.neutral None None None None I
D/T 0.8058 likely_pathogenic 0.7664 pathogenic 0.001 Stabilizing 0.983 D 0.739 prob.delet. None None None None I
D/V 0.9451 likely_pathogenic 0.923 pathogenic 0.268 Stabilizing 0.978 D 0.762 deleterious N 0.511909389 None None I
D/W 0.9976 likely_pathogenic 0.9972 pathogenic -0.47 Destabilizing 0.999 D 0.736 prob.delet. None None None None I
D/Y 0.9254 likely_pathogenic 0.9091 pathogenic -0.241 Destabilizing 0.999 D 0.744 deleterious D 0.536054031 None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.